171 related articles for article (PubMed ID: 19937477)
1. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
Konstantinidis IT; Deshpande V; Zheng H; Wargo JA; Fernandez-del Castillo C; Thayer SP; Androutsopoulos V; Lauwers GY; Warshaw AL; Ferrone CR
J Gastrointest Surg; 2010 Feb; 14(2):261-7. PubMed ID: 19937477
[TBL] [Abstract][Full Text] [Related]
2. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
3. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
[TBL] [Abstract][Full Text] [Related]
6. Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study.
Hashimoto D; Satoi S; Ishida M; Nakagawa K; Kotsuka M; Takagi T; Ryota H; Terai T; Sakaguchi T; Nagai M; Yamaki S; Akahori T; Yamamoto T; Sekimoto M; Sho M
Pancreatology; 2021 Aug; 21(5):884-891. PubMed ID: 33773918
[TBL] [Abstract][Full Text] [Related]
7. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.
Bhatti I; Peacock O; Awan AK; Semeraro D; Larvin M; Hall RI
World J Surg; 2010 Apr; 34(4):768-75. PubMed ID: 20052471
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
Zheng ZJ; Wang MJ; Tan CL; Chen YH; Ping J; Liu XB
Medicine (Baltimore); 2020 Feb; 99(8):e19327. PubMed ID: 32080152
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.
Elshaer M; Gravante G; Kosmin M; Riaz A; Al-Bahrani A
Ann R Coll Surg Engl; 2017 Feb; 99(2):101-106. PubMed ID: 27869496
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
[TBL] [Abstract][Full Text] [Related]
12. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
13. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
[TBL] [Abstract][Full Text] [Related]
14. Peritumoral lymph nodes in pancreatic cancer revisited; is it truly equivalent to lymph node metastasis?
Byun Y; Lee KB; Jang JY; Han Y; Choi YJ; Kang JS; Kim H; Kwon W
J Hepatobiliary Pancreat Sci; 2021 Oct; 28(10):893-901. PubMed ID: 33735543
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
[TBL] [Abstract][Full Text] [Related]
17. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Extensive Lymph Node Metastases for Resected Pancreatic Cancer.
Lowder CY; Metkus J; Epstein J; Kozak GM; Lavu H; Yeo CJ; Winter JM
Ann Surg Oncol; 2018 Dec; 25(13):4004-4011. PubMed ID: 30225835
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
